BeOne Medicines
ONC
#649
Rank
โ‚น3.219 T
Marketcap
โ‚น29,091
Share price
-2.56%
Change (1 day)
65.50%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

EPS for BeOne Medicines (ONC)

EPS in 2025 (TTM): โ‚น59.27

According to BeOne Medicines's latest financial reports the company's current EPS (TTM) is โ‚น58.56. In 2024 the company made an earnings per share (EPS) of -โ‚น562.19.

EPS history for BeOne Medicines from 2015 to 2025

Annual EPS

Year EPS Change
2025 (TTM)โ‚น59.27-110.54%
2024-โ‚น562.19
2022-โ‚น1,75728.21%
2021-โ‚น1,370-19.96%
2020-โ‚น1,71220.81%
2019-โ‚น1,41731.52%
2018-โ‚น1,078417.57%
2017-โ‚น208.19-37.16%
2016-โ‚น331.32158.95%
2015-โ‚น127.95

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Onconova Therapeutics
ONTX
-โ‚น85.59-246.15%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
-โ‚น21.62-136.92%๐Ÿ‡บ๐Ÿ‡ธ USA